Bridge to Industry (B2I) Grants are awarded to young researchers on the brink of becoming independent investigators, and are intended as seed money to help launch the scientific programs of promising new neuromuscular disease researchers with an interest in drug development. These grants are for $60,000 per year for one to three years, and the program must involve both academia and industry and have a drug development focus.
MDA will consider an application from a candidate who may be a member of a research team in the laboratory of an independent investigator (principal investigator) under whose guidance the applicant will be given flexibility to conduct a neuromuscular disease research project. Applicants must have a mentor both at a university and one at a drug development company, with work performed at both institutions.
Muscular Dystrophy Association — USA
222 S. Riverside Plaza, Suite 1500
Chicago, Illinois 60606
The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization.
©2015, Muscular Dystrophy Association Inc. All rights reserved.